Prospective, noninterventional study of vinflunine treatment in advanced urothelial cell carcinoma (UCC) in routine clinical practice.
Margitta Retz
No relevant relationships to disclose
Patrick De Geeter
No relevant relationships to disclose
Peter J. Goebell
Honoraria - Amgen; Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Janssen-Cilag; Novartis; Pfizer; Roche; Sanofi
Ullrich Matz
No relevant relationships to disclose
Wito de Schultz
No relevant relationships to disclose
Axel Hegele
Honoraria - Amgen; Novartis; Pierre Fabre Medicament